pubmed:abstractText |
TZT-1027 (Soblidotin), a microtubule-depolymerizing agent, has antivascular activity which disrupts newly formed tumor vasculature. In this study, it was investigated whether TZT-1027 has also antiangiogenic activity preventing neovascularization.
|
pubmed:affiliation |
ASKA Pharmaceutical Co., Ltd., Research and Development Division, 1604 Shimosakunobe, Takatsu-ku, Kawasaki-shi, Kanagawa 213-8522, Japan. watanabe-j@askapharma.co.jp
|